We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...

Afghanistan's de facto authorities have made the alarming decision to ban women from studying nursing and midwifery.1 This policy, along with the broader ban on girls completing education beyond grade ...

Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...

Artificial intelligence (AI) for mammography is an early exemplar of the integration of AI systems into clinical pathways and ...

The global incidence of cancer reached 20 million in 2022 and is projected to rise to 33·1 million by 2050.1 Amid the growing ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...

A 58-year-old male patient presented to the dermatology clinic at West China Hospital of Sichuan University (Chengdu, Sichuan ...